Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HYLO NIGHT
- Development stage
- Phase 3
- Lead developer
- URSAPHARM Arzneimittel
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
**HYLO NIGHT** is a preservative-free ophthalmic lubricant ointment marketed for night-time relief of dry-eye symptoms, including burning, irritation, itching, foreign-body sensation, and ocular dryness. The product contains white petrolatum and mineral oil, lanolin, and light mineral oil, with retinyl palmitate as an inactive ingredient. Applied to the eye before sleep, its viscous lipid-based ointment spreads across the ocular surface, supplements the tear-film lipid barrier, reduces evaporative moisture loss, and provides prolonged physical protection during the night. HYLO NIGHT was developed by Ursapharm and is marketed in the United States as OPTASE HYLO Night by Scope Eyecare.
- Brand names
- HYLO NIGHTOPTASE HYLO NightVitA-POS
- Other names
- HYLO NIGHT eye ointmentvitamin A eye ointment
Beyond the preview
Go deeper on HYLO NIGHT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HYLO NIGHT.